ANGIOTENSIN AMIDE

ID: ALA409803

Max Phase: Phase

Molecular Formula: C49H70N14O11

Molecular Weight: 1031.19

Molecule Type: Protein

Associated Items:

Representations

Synonyms (2): Asn-arg-val-tyr-val-his-pro-phe | NSC-107678
Synonyms from Alternative Forms(2):

    Canonical SMILES:  CC(C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C

    Standard InChI:  InChI=1S/C49H70N14O11/c1-26(2)39(61-42(67)33(12-8-18-55-49(52)53)57-41(66)32(50)23-38(51)65)45(70)58-34(20-29-14-16-31(64)17-15-29)43(68)62-40(27(3)4)46(71)59-35(22-30-24-54-25-56-30)47(72)63-19-9-13-37(63)44(69)60-36(48(73)74)21-28-10-6-5-7-11-28/h5-7,10-11,14-17,24-27,32-37,39-40,64H,8-9,12-13,18-23,50H2,1-4H3,(H2,51,65)(H,54,56)(H,57,66)(H,58,70)(H,59,71)(H,60,69)(H,61,67)(H,62,68)(H,73,74)(H4,52,53,55)/t32-,33-,34-,35-,36-,37-,39-,40-/m0/s1

    Standard InChI Key:  JYPVVOOBQVVUQV-CGHBYZBKSA-N

    Associated Targets(non-human)

    Angiotensin II receptor 1735 Activities

    Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

    Rattus norvegicus 775804 Activities

    Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

    Angiotensin II type 1a (AT-1a) receptor 1700 Activities

    Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

    Molecule Features

    Natural Product: NoOral: NoChemical Probe: NoParenteral: No
    Molecule Type: ProteinTopical: NoFirst In Class: NoBlack Box: No
    Chirality: YesAvailability: NoProdrug: No

    Drug Indications

    MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

    Mechanisms of Action

    Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

    Properties

    Molecular Weight: 1031.19Molecular Weight (Monoisotopic): 1030.5348AlogP: #Rotatable Bonds:
    Polar Surface Area: Molecular Species: HBA: HBD:
    #RO5 Violations: HBA (Lipinski): HBD (Lipinski): #RO5 Violations (Lipinski):
    CX Acidic pKa: CX Basic pKa: CX LogP: CX LogD:
    Aromatic Rings: Heavy Atoms: QED Weighted: Np Likeness Score:

    References

    1. Hsieh KH, Marshall GR..  (1986)  Role of the C-terminal carboxylate in angiotensin II activity: alcohol, ketone, and ester analogues of angiotensin II.,  29  (10): [PMID:3761315] [10.1021/jm00160a028]
    2. Samanen J, Narindray D, Cash T, Brandeis E, Adams W, Yellin T, Eggleston D, DeBrosse C, Regoli D..  (1989)  Potent angiotensin II antagonists with non-beta-branched amino acids in position 5.,  32  (2): [PMID:2913307] [10.1021/jm00122a030]
    3. Hsieh KH, LaHann TR, Speth RC..  (1989)  Topographic probes of angiotensin and receptor: potent angiotensin II agonist containing diphenylalanine and long-acting antagonists containing biphenylalanine and 2-indan amino acid in position 8.,  32  (4): [PMID:2704034] [10.1021/jm00124a028]
    4. USP Dictionary of USAN and International Names (2010 edition) and USAN registrations 2007-date, 
    5. Hsieh K, Jorgensen EC, Lee TC..  (1979)  Angiotensin II analogues. 12. Role of the aromatic ring of position 8 phenylalanine in pressor activity.,  22  (9): [PMID:490548] [10.1021/jm00195a005]
    6. Galardy RE, Stafford SS, Schaefer ML, Ho H, La Vorgna KA, Jamieson JD..  (1978)  Biologically active derivatives of angiotensin for labeling cellular receptors.,  21  (12): [PMID:214560] [10.1021/jm00210a020]
    7. WHO Anatomical Therapeutic Chemical Classification,